These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


523 related items for PubMed ID: 7677385

  • 1. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG, Kaan EC, Christen MO, Löw-Kröger A, Mest HJ, Molderings GJ.
    Ann N Y Acad Sci; 1995 Jul 12; 763():659-72. PubMed ID: 7677385
    [Abstract] [Full Text] [Related]

  • 2. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
    Ernsberger P, Haxhiu MA, Graff LM, Collins LA, Dreshaj I, Grove DL, Graves ME, Schäfer SG, Christen MO.
    Cardiovasc Drugs Ther; 1994 Mar 12; 8 Suppl 1():27-41. PubMed ID: 8068578
    [Abstract] [Full Text] [Related]

  • 3. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA, Dreshaj I, Schäfer SG, Ernsberger P.
    J Cardiovasc Pharmacol; 1994 Mar 12; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [Abstract] [Full Text] [Related]

  • 4. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN, Graham BR.
    Drugs Aging; 2000 Aug 12; 17(2):133-59. PubMed ID: 10984201
    [Abstract] [Full Text] [Related]

  • 5. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA.
    Ann N Y Acad Sci; 1999 Jun 21; 881():279-86. PubMed ID: 10415926
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X, Li G, Abdel-Rahman AA.
    Eur J Pharmacol; 2005 May 09; 514(2-3):191-9. PubMed ID: 15910806
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN, Owens CW, Graham BR.
    J Hum Hypertens; 1997 Aug 09; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [Abstract] [Full Text] [Related]

  • 9. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B, Urban R.
    Arzneimittelforschung; 1997 Sep 09; 47(9):1009-15. PubMed ID: 9342413
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Mest HJ, Thomsen P, Raap A.
    Ann N Y Acad Sci; 1995 Jul 12; 763():620-33. PubMed ID: 7677382
    [Abstract] [Full Text] [Related]

  • 12. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
    Ernsberger P, Friedman JE, Koletsky RJ.
    J Hypertens Suppl; 1997 Jan 12; 15(1):S9-23. PubMed ID: 9050981
    [Abstract] [Full Text] [Related]

  • 13. Historic aspects in the identification of the I1 receptor and the pharmacology of imidazolines.
    Dominiak P.
    Cardiovasc Drugs Ther; 1994 Mar 12; 8 Suppl 1():21-6. PubMed ID: 8068577
    [Abstract] [Full Text] [Related]

  • 14. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents.
    Head GA, Chan CK, Burke SL.
    J Auton Nerv Syst; 1998 Oct 15; 72(2-3):163-9. PubMed ID: 9851565
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
    Ziegler D, Haxhiu MA, Kaan EC, Papp JG, Ernsberger P.
    J Cardiovasc Pharmacol; 1996 Oct 15; 27 Suppl 3():S26-37. PubMed ID: 8872297
    [Abstract] [Full Text] [Related]

  • 18. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK, Burke SL, Zhu H, Piletz JE, Head GA.
    Neuroscience; 2005 Oct 15; 132(4):991-1007. PubMed ID: 15857704
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.